Arrowhead Pharmaceuticals Inc.

XNAS:ARWR

56.33

-0.63 (-1.11%)

7:59:50 PM EDT: $57.18 +0.85 (+1.51%)

Market Cap (Intraday)	7.80B
Current PE	38.57
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$71.51 Million
Adjusted EPS	-$1.04

See more estimates

10-Day MA	$57.75
50-Day MA	$63.61
200-Day MA	$41.30

See more pivots

Arrowhead Pharmaceuticals Inc. Stock, XNAS:ARWR

177 East Colorado Boulevard, Suite 700, Pasadena, California 91105

United States of America

Phone: +1.626.304.3400

Number of Employees: 609

http://www.arrowheadpharma.com

Description

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.